RGS16 is a marker for prognosis in colorectal cancer

Norikatsu Miyoshi, Hideshi Ishii, Mitsugu Sekimoto, Yuichiro Doki, Masaki Mori

研究成果: ジャーナルへの寄稿学術誌査読

18 被引用数 (Scopus)


Background: The RGS family, comprising 22 homologues of proteins, plays a role in cellular proliferation, differentiation, membrane trafficking, and embryonic development through the involvement of the mitogen-activated protein kinase signaling pathway. Methods: In order to demonstrate the importance of RGS16 expression for the prediction of prognosis of colorectal cancer (CRC), we analyzed RGS16 gene expression in 22 human gastrointestinal cell lines and 124 paired cases of CRC and noncancerous regions. Results: RGS16 was expressed in 17 human gastrointestinal cancer cell lines examined in this study. RGS16 expression was higher in colorectal cancer tissue than in corresponding normal tissue (P < 0.001) in messenger RNA (mRNA) and protein levels. Patients in the RGS16 high-expression group showed a poorer overall survival rate than those in the low-expression group (P < 0.001), indicating that high RGS16 expression was an independent prognostic factor. Conclusion: The present study suggests that RGS16 is useful as a predictive marker for patient prognosis of CRC.

ジャーナルAnnals of Surgical Oncology
出版ステータス出版済み - 12月 2009

!!!All Science Journal Classification (ASJC) codes

  • 外科
  • 腫瘍学


「RGS16 is a marker for prognosis in colorectal cancer」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。